ONE HEALTH APPROACHES TO MITIGATE AND MANAGE INFECTIONS IN HUMANS AND ANIMALS

The AMR Alliance will focus on all types of infections to catalyse engagement and maximise opportunity to coalesce expertise, for example, across genomics, experimental science, drug discovery, diagnostics and clinical, public health and environmental science as well as engage with national and international agencies. This is timely due to the clear links to COVID-19 and patient susceptibility to contracting secondary bacterial and fungal infections. We anticipate that this may lead to further targeted research areas, for example, secondary infections, hospital acquired infections and community infections.